Skip to content

Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes

Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes. A French Monocentric Prospective Study (IM-CAPT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03177096
Acronym
IM-CAPT
Enrollment
14
Registered
2017-06-06
Start date
2016-09-20
Completion date
2017-07-12
Last updated
2019-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1diabetes

Keywords

Type 1 diabetes children,School,Childcare facilities,Sensor

Brief summary

The implementation of a sensor of glycemia Enlite coupled with an insulin pump (Medtronic Minimed 640G) is a therapeutic option that Hospital of Mulhouse can propose to the children affected by type 1 diabetes. The glycemic rate detected by the sensor of continuous measure of the glycemia is visible in real time on the pump and then the rate can be normalized. The study will evaluate the impact of the continuous measurement of blood glucose on insulin pump on child quality of life with type 1 diabetes aged 2 to 13 years old.

Detailed description

The French High Health Authority recommends, for patient with type1 diabetes, a supervision of at least 4 tests a day in pre and post prandial with additional controls in circumstances of meal or of unusual physical activities. Du to age, this control need supervision of an adult, in each place of children life (school, nursery, out-of-school center ...), according to their autonomy. During several years, all the actors of educational care tried to improve the welcome of the children affected by handicap or by chronic disease. Since 10 years, the team of pediatric diabetology of Mulhouse Hospital has developed a partnership with the department of Education by setting up every year in September of a training courses for voluntary teachers and all staff nursery. These sessions are consisted of a formal time bringing knowledge on the disease, followed by exchanges and finally a practical time around manipulation of the readers of glycemia and pumps. Alerts can be scheduled to warm an increase or an important reduction of blood glucose. The study will evaluate the child quality of life, and also parents and staffs in preschool, school or in out-of-school center felt too.

Interventions

BEHAVIORALPeds QL questionnaire and diabetes modulate

Peds QL questionnaire and diabetes modulate is a pediatric questionnaire about quality of life - children's version and parents version : assessed in the 1st visit (enrollment visit) and after ten months ( V6 End of study)

BEHAVIORALWHO-5 questionnaire

WHO-5 questionnaire is a questionnaire about quality of life : assessed in the 1st visit (enrollment visit) and after ten months (V6 End of Study) by the children

BEHAVIORALFelt questionnaire

Felt questionnaire completed by parents with regard to the welcome of their child in community and by the staffs in preschool, school or in out-of school center : assessed 2 months (V2) and ten months (V6 End of study) after enrollment visit

Sponsors

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* Enrollment between September 15 to November 15, 2016 * Insulin-dependent Type 1 Diabetes with insulin pump * From 2 to 13 years old * Schooled to the nursery or primary school, seeing frequently a day-nursery or in an out-of-school center * Treated at the hospital of Mulhouse, France

Exclusion criteria

* Opposition to study participation * Patients who don't need sensor of measure of the continuous glycemia

Design outcomes

Primary

MeasureTime frameDescription
Evolution of Peds QL questionnaire resultsThrough study completion, an average of 10 monthsQuestionnaire of quality of life (QL)

Secondary

MeasureTime frameDescription
Evolution of WHO-5 and felt questionnairethrough study completion, an average of 10 monthsQuestionnaire of quality of life

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026